Trials24

Munchen, Germany Founded: 2017 • Age: 9 yrs Acquired By SubjectWell
Patient recruitment and engagement platform for clinical trials is provided.

About Trials24

Trials24 is a Healthcare company based in Munchen (Germany) founded in 2017, and was acquired by SubjectWell in September 2024. Patient recruitment and engagement platform for clinical trials is provided. Trials24 offers products and services including SubjectWell+ Platform, Patient Companions, and Virtual Waiting Room. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its legal entity is Trials24 GmbH.

Company details

Trials24 was founded in 2017 in Munich, Germany, as a provider in the clinical trials sector. A platform for patient recruitment and engagement is offered, supporting trials across therapeutic areas such as rare diseases, infectious diseases, and cancers. Target patients are identified in online spaces, patient communities, or through organizations. Patient information is supplied, screening is conducted, and guidance is provided throughout the process.

Key Metrics

Products & Services of Trials24

Trials24 offers a comprehensive portfolio of products and services, including SubjectWell+ Platform, Patient Companions, and Virtual Waiting Room.

SubjectWell+ Platform
Patient Recruitment Platform

Technology platform for managing clinical trial recruitment and site operations

Patient Companions
Support Services

Services to assist patients and sites during clinical trials processes

Virtual Waiting Room
Engagement Tools

Tool to keep patients engaged while awaiting trial readiness

Investors in Trials24

Trials24 has secured backing from 1 investor. Prominent investors backing the company include SubjectWell.

All
InvestorDescriptionFounded YearDomainLocation
Clinical trials marketplace for patient recruitment solutions is provided.
2012subjectwell.comAustin, United States
Premium access

Investor details for Trials24

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Trials24

2 dated milestones of Trials24 across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Trials24 is founded.
  2. Exit Acquired by SubjectWell.

Web traffic of Trials24

The website of Trials24 (trials24.com) receives about 1K visits a month.

  • Monthly visits
    1K

    ▼ 28% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track โ€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • โœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • โœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • โœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Trials24

SubjectWell’s Acquisition of Trials24
Globallegalchronicle โ€ข 2 years ago
Premium access

Complete news archive for Trials24

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Trials24

Trials24 was founded in 2017.

Trials24 is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.

Trials24 was founded in 2017 in Munich, Germany, as a provider in the clinical trials sector. A platform for patient recruitment and engagement is offered, supporting trials across therapeutic areas such as rare diseases, infectious diseases, and cancers. Target patients are identified in online spaces, patient communities, or through organizations. Patient information is supplied, screening is conducted, and guidance is provided throughout the process.

Trials24 offers SubjectWell+ Platform, Patient Companions, and Virtual Waiting Room.

Trials24 has 1 investor. Key investors include SubjectWell.

Trials24 operates through Trials24 Gmbh.

Yes. Trials24 was acquired by SubjectWell in September 2024.

Explore millions of companies โ€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals โ€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available